1. Nicolantonio FD, Sartore-Bianchi A, Molinari Fet al.BRAF,PIK3CA, andKRASmutations and loss ofPTENexpression impair response toEGFR-targeted therapies in metastatic colorectal cancer. Presented at:100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract LB-93).
2. Tykocinski ES, Kapoor GS, Grant Ret al.Identification of theEGFRvIIImutation in glioblastoma by magnetic resonance perfusion-weighted imaging and VEGF expression. Presented at:100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract LB-95).
3. Sorensen AG, Batchelor TT, Ancukiewicz Met al.A “vascular normalization index” as a mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients: insights from a Phase II study. Presented at:100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract LB-94).
4. Stegmaier K. Gene expression-based approaches to small molecule discovery for cancer. Presented at:100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract SY08-2).
5. Graves JA, Rothermund K, Prochownik EV. Genomic instability is not required for the acute transforming phenotype ofc-Myc. Presented at:100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 1885).